[144] Newegg Commerce, Inc. SEC Filing
Newegg Commerce, Inc. (NEGG) filed a Form 144 notifying a proposed sale of 16,135 shares of common stock through Fidelity Brokerage Services LLC with an aggregate market value of $1,000,448.59. The securities are reported as outstanding totaling 19,478,394 shares and the approximate sale date is listed as 08/27/2025 on the NASDAQ. The filing shows the shares arise from an option granted on 06/15/2020 and the acquisition/transfer date is recorded as 08/27/2025, with payment by cash. The filer reports no securities sold in the past three months and includes the standard signature representation regarding absence of undisclosed material adverse information.
- Complete disclosure of sale details: broker, share count, aggregate market value, outstanding shares, and approximate sale date are provided
- Origin of shares identified as from an option granted on 06/15/2020, clarifying the nature of the holdings to be sold
- No sales in prior three months reported for the person whose account is to be sold
- None.
Insights
TL;DR: Officer/insider intends to sell 16,135 NEGG shares via Fidelity for ~$1.00M; proceeds stem from an option grant dated 06/15/2020.
The Form 144 indicates a proposed sale executed through a registered broker with clear identification of class, quantity, aggregate value, and an approximate sale date. The securities are identified as originating from an option grant, suggesting this is a planned disposition of previously granted equity rather than a market acquisition. The filing notes no sales in the prior three months, which may be relevant to short-term insider trading patterns. This is a routine regulatory disclosure required for covered securities sales.
TL;DR: Filing appears procedurally complete with broker and acquisition details; signer affirms no undisclosed material information.
The notice includes required elements: broker name and address, share count, aggregate market value, outstanding share count, and origin of shares (option grant). The representation regarding absence of undisclosed material information and the signature warning about false statements are present, aligning with regulatory compliance expectations. No prior three-month sales are reported, and payment method is cash. The document does not disclose any material adverse events or unusual trading arrangements.